Jefferies Group LLC Abiomed Inc Call Options Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Sep 21, 2023	BUY	$224.73 - $338.64 $1.69 Million - $2.54 Million	7,500 New	7,500 $1.86 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $1.69 Million - $2.54 Million	7,500 New	7,500 $1.86 Million
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $353,500 - $642,724	-2,500 Closed	0 $0
Q1 2020 Nov 24, 2020	BUY	$130.51 - $196.01 $326,275 - $490,025	2,500 New	2,500 $372,000
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $3.54 Million - $5.6 Million	-12,600 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $5.5 Million - $6.97 Million	-15,500 Reduced 55.16%	12,600 $5.67 Million
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $834,210 - $1.34 Million	3,000 Added 11.95%	28,100 $11.5 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $4.83 Million - $7.43 Million	25,100 New	25,100 $7.3 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.